| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $447.7M | -1.3% | +10.9% |
| Cost of Revenue | $318.3M | -1.3% | +8.9% |
| Gross Profit | $129.4M | -1.2% | +16.3% |
| R&D Expense | $10.0M | -6.5% | +3.1% |
| SG&A Expense | $45.9M | -0.4% | -1.1% |
| Operating Income | $81.9M | +0.2% | +29.6% |
| Pre-tax Income | $71.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $218.3M | +14.4% | +10.9% |
| Accounts Receivable | $323.6M | -2.6% | +25.5% |
| Inventory | $302.8M | +6.2% | +7.3% |
| Current Assets | $883.5M | +3.2% | +13.4% |
| Total Assets | $1.34B | +1.9% | +9.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $155.2M | — | — |
| Capital Expenditures | $37.6M | — | — |
| Investing Cash Flow | -$37.6M | — | — |
| Financing Cash Flow | -$88.1M | — | — |
| Free Cash Flow | $117.6M | — | — |
| -6.5% |
| +33.5% |
| Income Tax | $16.9M | +0.6% | +70.7% |
| Net Income | $54.8M | -8.5% | +25.1% |
| EPS (Basic) | $0.67 | -8.2% | +26.4% |
| EPS (Diluted) | $0.66 | -8.3% | +26.9% |
| $412.5M |
| +3.4% |
| +12.0% |
| Long-term Debt | $577.5M | -1.3% | -3.1% |
| Total Liabilities | $1.00B | +0.5% | +0.6% |
| Stockholders' Equity | $336.7M | +6.4% | +52.2% |